Enveric Biosciences announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 12 pre-split shares. The reverse stock split will become effective at 8:00 a.m., New York time, on Tuesday, October 28. Enveric’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol (ENVB) and will begin trading on a split-adjusted basis when the market opens on Tuesday, October 28.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVB:
- Psychedelic: Needham initiates coverage of atai, GH Research, MindMed
- Enveric Biosciences issued patent for neuroplastogenic novel compounds
- Enveric hires firm to contest post-grant review petition filed by Gilgamesh
- Enveric Biosciences to explore digital asset treasury strategy opportunities
- Psychedelic: Enveric announces EB-003 manufacturing milestones